Skip to search formSkip to main contentSkip to account menu

DNA Vaccine VB10.16

Known as: VB10.16, VB10.16 Vaccine 
A therapeutic DNA vaccine composed of three parts, one encodes the E6/E7 fusion protein of human papillomavirus (HPV) type 16 (HPV16), the second is… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND: Persistent HPV infection can lead to high-grade squamous intraepithelial lesions (HSIL) in cervical cells; current… 
2019
2019
Introduction/Background This was an exploratory, multicenter study of VB10.16 immunotherapy in patients with HPV16+ CIN 2/3…